INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP
Data sourced from IRS 990 public filings
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the disciplines. The academic journal Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies, has reopened More than 2000 patients are enrolled. The Biology Working Group has been created, .
Annual Revenue
$377,806
Known Funders
2
Grants Received
2
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $373,790 | $229,580 | $312,142 |
| 2023 | $164,486 | $142,903 | $167,923 |
Top Funders
SHELTON, CT
Key Personnel
From 2024 IRS 990 filing
Dr Dirk Van Raemdonck
Vjce President
Dr Annemarie Fernandes Shepherd
Treasurer
Dr Paolo Mendogni
Secretary
Dr Malgorzata Szolkowska
President
Pam Bruce
Director
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.